Postoperative morbidity after bowel resections in patients with Crohn's disease: Risk, management strategies, prevention;Postoperative Komplikationen nach Darmresektionen bei Patienten mit Morbus Crohn: Risiko, Behandlung, Prävention

Zeitschrift fur Gastroenterologie

Volumn 50, Issue 6, 2012, Pages 595-600

  Iesalnieks, I ^a,b   Dederichs, F ^c   Kilger, A ^d   Schlitt, H J ^b   Agha, A ^b  

^a Abteilung für Allgemein und Viszeralchirurgie   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c Abteilung für Innere Medizin und Gastroenterologie   (Germany)

^d Klinikum Deggendorf   (Germany)

Author keywords

Crohn's disease; outcome; surgery

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; STEROID;

ABDOMINAL ABSCESS; ABSCESS DRAINAGE; ANASTOMOSIS LEAKAGE; ANTIBIOTIC THERAPY; ARTICLE; CROHN DISEASE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENTERIC FEEDING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FISTULA; INTESTINE RESECTION; PERCUTANEOUS DRAINAGE; PERITONITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RISK REDUCTION; SURGICAL RISK; WEIGHT REDUCTION;

COMORBIDITY; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; INTESTINES; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 84861843001     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0031-1299462     Document Type: Article

References (55)

1. Olaison G, Sjödahl R, Tagesson C. Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. Gut: 1990; 31 325 328 (Pubitemid 20093672)
2. Lazarev M, Ullman T, Schraut WH et al. Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis: 2010; 16 830 835
3. Jones DW, Finlayson SR. Trends in surgery for Crohn's disease in the era of infliximab. Ann Surg: 2010; 252 307 312
4. Peyrin-Biroulet L, Oussalah A, Williet N et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut: 2011; 60 930 936
5. Penner RM, Madsen KL, Fedorak RN. Postoperative Crohn's disease. Inflamm Bowel Dis: 2005; 11 765 777 (Pubitemid 41271182)
6. Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol: 2009; 104 2089 2096
7. Regueiro M, Schraut W, Baidoo L et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology: 2009; 136 441 450
8. Savarino E, Dulbecco P, Bodini G et al. Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol: 22 12 2011; [Epub ahead of print]
9. Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis: 2008; 14 709 720 (Pubitemid 351742998)
10. Iesalnieks I, Kilger A, Glass H et al. Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis: 2008; 23 1167 1174
11. Iesalnieks I, Kilger A, Glass H et al. Perforating Crohn's ileitis: delay of surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis: 2010; 16 2125 2130
12. Post S, Betzler M, von Ditfurth B et al. Risks of intestinal anastomoses in Crohn's disease. Ann Surg: 1991; 213 37 42
13. Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum: 2000; 43 1141 1145 (Pubitemid 30626148)
14. Alves A, Panis Y, Bouhnik Y et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum: 2007; 50 331 336 (Pubitemid 46393968)
15. Bruewer M, Utech M, Rijcken EJ et al. Preoperative steroid administration: effect on morbidity among patients undergoing bowel resection for Crohn's disease. World J Surg: 2003; 27 1306 1310 (Pubitemid 37543025)
16. Heimann TM, Greenstein AJ, Mechanic L et al. Early complications following surgical treatment for Crohn's disease. Ann Surg: 1985; 201 494 498 (Pubitemid 15042049)
17. Appau KA, Fazio VW, Shen B et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg: 2008; 12 1738 1744
18. Resegotti A, Astegiano M, Farina EC et al. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery. Dis Colon Rectum: 2005; 48 464 468 (Pubitemid 40767866)
19. Zerbib P, Koriche D, Truant S et al. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease. Aliment Pharmacol Ther: 2010; 32 459 465
20. Tay GS, Binion DG, Eastwood D et al. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery: 2003; 134 565 572
21. Samimi R, Flasar MH, Kavic S et al. Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study. Inflamm Bowel Dis: 2010; 16 1187 1194
22. Muñoz-Juárez M, Yamamoto T, Wolff BG et al. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum: 2001; 44 20 25
23. Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis: 2000; 6 8 15
24. Satsangi J, Silverberg MS. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut: 2006; 55 749 753 (Pubitemid 43764536)
25. Louis E, Collard A. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of disease. Gut: 2001; 49 777 782 (Pubitemid 33096034)
26. Oostenbrug LE, van Dullemen HM. Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol: 2006; 18 255 261
27. Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut: 1988; 29 588 592
28. Nasir BS, Dozois EJ, Cima RR et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease. J Gastrointest Surg: 2010; 14 1859 1865
29. Ozuner G, Fazio VW, Lavery IC et al. How safe is strictureplasty in the management of Crohn's disease? Am J Surg: 1996; 171 57 60 (Pubitemid 126349876)
30. Dietz DW, Laureti S, Strong SA et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease. J Am Coll Surg: 2001; 192 330 337
31. Fearnhead NS, Chowdhury R, Box B et al. Long-term follow-up of strictureplasty for Crohn's disease. Br J Surg: 2006; 93 475 482
32. Subramanian V, Saxena S, Kang JY et al. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol: 2008; 103 2373 2381
33. Colombel JF, Loftus EV Jr, Tremaine WJ et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol: 2004; 99 878 883 (Pubitemid 39090217)
34. Lorenz D, Lorenz U, Hagmüller E et al. Morbus Crohn: Resektionstherapie im Verlauf von zwei Jahrzehnten. Zentralbl Chir: 1993; 118 127 133
35. Simillis C, Purkayastha S, Yamamoto T et al. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum: 2007; 50 1674 1687 (Pubitemid 47583357)
36. Smedh K, Andersson M, Johansson H et al. Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn's disease. Eur J Surg: 2002; 168 154 157 (Pubitemid 34712959)
37. McLeod RS, Wolff BG, Ross S et al. Investigators of the CAST Trial. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum: 2009; 52 919 927
38. Jeejeebhoy KN, Detsky AS, Baker JP. Assessment of nutritional status. JPEN J Parenter Enteral Nutr: 1990; 14 193S 196S (Pubitemid 20317198)
39. Weimann A, Braga M, Harsanyi L et al. ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr: 2006; 25 224 244 (Pubitemid 43832525)
40. Müller-Wille R, Iesalnieks I, Dornia C et al. Influence of percutaneous abscess drainage on severe postoperative septic complications in patients with Crohn's disease. Int J Colorectal Dis: 2011; 26 769 774
41. Goyer P, Alves A, Bretagnol F et al. Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients. Dis Colon Rectum: 2009; 52 205 210
42. Iesalnieks I, Kilger A, Kalisch B et al. Treatment of the anastomotic complications in patients with Crohn's disease. Int J Colorectal Dis: 2011; 26 239 244
43. Myrelid P, Söderholm JD, Olaison G et al. Split stoma in resectional surgery of high risk patients with ileocolonic Crohn's disease. Colorectal Dis: 2012; 14 188 193
44. Longo WE, Oakley JR, Lavery IC et al. Outcome of ileorectal anastomosis for Crohn's colitis. Dis Colon Rectum: 1992; 35 1066 1071
45. Fichera A, McCormack R, Rubin MA et al. Long-term outcome of surgically treated Crohn's colitis: a prospective study. Dis Colon Rectum: 2005; 48 963 969 (Pubitemid 40884185)
46. Iesalnieks I, Glaß H, Kilger A et al. Perianale Crohn-Fisteln - Ergebnisse der Behandlung in einer interdisziplinären Sprechstunde. Chirurg: 2009; 80 549 558
47. Iesalnieks I, Gaertner WB, Glass H et al. Fistula-associated anal adenocarcinoma in Crohn's disease. Inflamm Bowel Dis: 2010; 16 1643 1648
48. Sjödahl RI, Myrelid P, Söderholm JD. Anal and rectal cancer in Crohn's disease. Colorectal Dis: 2003; 5 490 495 (Pubitemid 37080660)
49. Amiot A, Gornet JM, Baudry C et al. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis: 2011; 43 698 702
50. Aydin HN, Remzi FH, Tekkis PP et al. Hartmann's reversal is associated with high postoperative adverse events. Dis Colon Rectum: 2005; 48 2117 2126 (Pubitemid 43035122)
51. Holzheimer RG, Molloy RG, Wittmann DH. Postoperative complications predict recurrence of Crohn's disease. Eur J Surg: 1995; 161 129 135
52. Khoury W, Strong SA, Fazio VW et al. Factors associated with operative recurrence early after resection for Crohn's disease. J Gastrointest Surg: 2011; 15 1354 1360
53. Iesalnieks I, Schlitt HJ, Agha A. Frühzeitiges Erkennen der postoperativen Komplikationen bei Patienten mit M. Crohn. 178. Jahrestagung der Vereinigung Niederrheinisch-Westfälischer Chirurgen. 20. und 21. Oktober 2011 Bochum Abstract.
54. Korner H, Nielsen HJ, Soreide JA et al. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg: 2009; 13 1599 1606
55. Matthiessen P, Henriksson M, Hallböök O et al. Increase of serum C-reactive protein is an early indicator of subsequent symptomatic anastomotic leakage after anterior resection. Colorectal Dis: 2008; 10 75 80 (Pubitemid 350238567)